中石化油服(01033.HK)註銷首次授予A股股票期權激勵計劃第三個行權期股票期權
格隆匯10月28日丨中石化油服(01033.HK)公吿,公司首次授予A股股票期權激勵計劃第三個行權期為2020年11月1日至2021年10月30日,由於在上述行權期內,公司A股股價較行權價(人民幣5.63元/股)一直相差較大,根據《上市公司股權激勵管理辦法》、《中石化石油工程技術服務股份有限公司A股股票期權激勵計劃(草案修訂稿)》(“《股票期權激勵計劃》”)的相關規定,股票期權各行權期結束後,激勵對象未行權的當期股票期權應當終止行權,上市公司應當及時註銷。
公司董事會(“董事會”)將對第三個行權期已到期尚未行權的423名激勵對象所持共計1,708.4萬份股票期權予以註銷。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.